Perspective Therapeutics, Inc. - COMMON STOCK (CATX)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
73,943,049
Total 13F shares
42,524,179
Share change
+430,096
Total reported value
$145,860,657
Price per share
$3.43
Number of holders
103
Value change
+$1,461,871
Number of buys
47
Number of sells
37

Institutional Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q3 2025

As of 30 Sep 2025, Perspective Therapeutics, Inc. - COMMON STOCK (CATX) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,524,179 shares. The largest 10 holders included FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avidity Partners Management LP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Nicholson Wealth Management Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, Nuveen, LLC, and STATE STREET CORP. This page lists 103 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.